PRESS RELEASE published on 07/17/2024 at 12:14, 1 year 4 months ago CHEPLAPHARM reorganises Management Team CHEPLAPHARM reorganises Management Team with new appointments and expanded responsibilities, preparing for the future. Artem Gevorkyan joins as Managing Director Corporate Business Development, Karl Lang leads Supply Chain & Logistics, Klaus Köhl leaves company Management Team Reorganization CHEPLAPHARM Artem Gevorkyan Karl Lang
BRIEF published on 04/26/2024 at 12:00, 1 year 7 months ago CHEPLAPHARM annonce un chiffre d'affaires et une croissance record au cours de l'exercice 2023 Croissance Financière Acquisitions Les Obligations De Sociétés Industrie Pharmaceutique CHEPLAPHARM
BRIEF published on 04/26/2024 at 12:00, 1 year 7 months ago CHEPLAPHARM Reports Record Revenue and Growth in Financial Year 2023 Pharmaceutical Industry Acquisitions Financial Growth Corporate Bonds CHEPLAPHARM
PRESS RELEASE published on 04/26/2024 at 11:55, 1 year 7 months ago CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth CHEPLAPHARM reports record revenue of €1.5 billion and 17% year-over-year growth in financial year 2023. EBITDA up 14% to €780.5 million with stable 52% margin. Expansion with new affiliates in Japan and Switzerland EBITDA Revenue Acquisitions Growth CHEPLAPHARM
BRIEF published on 04/03/2024 at 10:15, 1 year 8 months ago Caroline Jacquin nommée Directrice Générale de CHEPLAPHARM France SAS Changement De Direction Directeur Général Industrie Pharmaceutique Caroline Jacquin CHEPLAPHARM France SAS
BRIEF published on 04/03/2024 at 10:15, 1 year 8 months ago Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS Pharmaceutical Industry Managing Director Leadership Change Caroline Jacquin CHEPLAPHARM France SAS
PRESS RELEASE published on 04/03/2024 at 10:10, 1 year 8 months ago Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS, experienced pharmaceutical manager with 25 years in leading positions to lead the French subsidiary. Isabelle Dalle retiring Pharmaceutical Industry Managing Director Caroline Jacquin CHEPLAPHARM France SAS Isabelle Dalle
PRESS RELEASE published on 09/21/2023 at 13:41, 2 years 2 months ago CHEPLAPHARM succesfully places additional notes in a volume of €300m
PRESS RELEASE published on 09/12/2023 at 10:00, 2 years 2 months ago CHEPLAPHARM opens swiss subsidiary and wins Agnes Wasem as Managing Director
Published on 12/05/2025 at 02:35, 8 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 35 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 50 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 24 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 35 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 59 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 2 hours 20 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 20 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 2 hours 22 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 50 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 5 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025